Pipeline/Trials

Phase 1 and Phase 2 NSCLC imaging trial completed for 99mTc-Oncardia


Completing Phase 3 Lung Cancer Imaging Trial under FDA Special Protocol Assessment

ClinicalTrials.gov Identifier: NCT01394679

Completing Phase 2b/3 trial with 99mTc-Oncardia as the first “functional hot spot” cardiac ischemia imaging agent.

ClinicalTrials.gov Identifier: NCT01899833